Scleroderma renal crisis is a rare but serious complication of systemic sclerosis. It is usually associated with marked hypertension and carries significant risk for morbidity and mortality. Its occurrence prior to the development of skin sclerosis is exceedingly rare. We report a case of a patient who presented with recurrent pericardial effusion and later tested positive for anti-nuclear and anti-topoisomerase antibodies. He later developed normotensive renal crisis as confirmed by kidney biopsy despite complete absence of skin involvement. To our knowledge, this is the first published case of a patient presenting with normotensive renal crisis without any skin involvement.
SobanskiVGiovannelliJAllanoreY, et al. Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis. Arthritis Rheumatol2019; 71(9): 1553–1570.
2.
FettN. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol2013; 31(4): 432–437.
HunzelmannNGenthEKriegT, et al. The registry of the German network for systemic scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology2008; 47(8): 1185–1192.
6.
HayashiNKoshibaMNishimuraK, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol2008; 18(2): 153–160.
7.
HoKTReveilleJD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther2003; 5(2): 80–93.
8.
HomerKLWarrenJKarayevD, et al. Performance of anti-topoisomerase I antibody testing by multiple-bead, enzyme-linked immunosorbent assay and immunodiffusion in a university setting. J Clin Rheumatol2020; 26(3): 115–118.
9.
TokPLRoyDMNgAK, et al. Normotensive scleroderma renal crisis. Ann Acad Med Singap2018; 47(6): 223–225.
10.
ZwettlerUAndrassyKWaldherrR, et al. Scleroderma renal crisis as a presenting feature in the absence of skin involvement. Am J Kidney Dis1993; 22(1): 53–56.
11.
CanetJJCastañéJAlvarezM, et al. Scleroderma renal crisis sine scleroderma. Nephron2002; 90(1): 119–120.
12.
MokCCKwanTHChowL. Scleroderma renal crisis sine scleroderma during pregnancy. Scand J Rheumatol2003; 32(1): 55–57.
13.
HansrivijitPOmeonuKFLawalHO, et al. A 45-year-old man with scleroderma renal crisis associated with a history of systemic sclerosis sine scleroderma. Am J Case Rep2020; 21: e927030.
14.
JacquierMMoussonCRebibouJM, et al. Scleroderma renal crisis in a systemic sclerosis with anti-PM/Scl antibodies. Kidney Int Rep2019; 4(10): 1499–1502.
15.
MolinaJFAnayaJMCabreraGE, et al. Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis. J Rheumatol1995; 22(3): 557–560.
16.
AkogluHAtilganGKOzturkR, et al. A “silent” course of normotensive scleroderma renal crisis: case report and review of the literature. Rheumatol Int2009; 29(10): 1223–1229.
17.
BatalIDomsicRTShaferA, et al. Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol2009; 40(3): 332–340.
18.
SmithVHerrickALIngegnoliF, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev2020; 19(3): 102458.
19.
PhanTGCassAGillinA, et al. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma. J Rheumatol1999; 26(11): 2489–2492.
